This approach allows researchers to pinpoint antibody-secreting cells and isolate ... platform that enables discovery in a range of growing markets through single cell analysis.
In this approach, researchers first collect antibody-producing cells from mice exposed to an antigen of interest and fuse them to myeloma cells, forming so-called hybridomas that can survive for a ...
The Beacon ® single B cell sorting platform automatically ... thus quickening the process of antibody (drug) discovery. The company also offers mouse monoclonal antibody humanization services.
5 个月
Latin Times on MSNResearchers discover antibody that neutralizes all known COVID-19 variants, paving way for ...The technology behind SC27's discovery, known as Ig-Seq, combines single-cell DNA sequencing with proteomics, allowing ...
We use cookies to provide you with a better experience. You can read our Cookie Policy here. i-Ome™ Discovery is Sengenics’ most advanced protein microarray, meticulously designed for antibody and ...
A team from Osaka University has developed scSPOT, a new technique that reveals how immune cells called Tregs simultaneously ...
Antibody discovery relies on technologies that quickly identify candidates with therapeutic potential. However, traditional methods are labor-intensive, may not support high-throughput applications, ...
Antibodies have become an integral part of research and medicine. Therapeutic applications of antibodies began to emerge following the publication of Köhler and Milstein’s groundbreaking 1975 paper in ...
18 天
The Brighterside of News on MSNNew discovery revolutionizes treatment of autoimmune disordersA breakthrough discovery in enzyme science could revolutionize the treatment of autoimmune disorders and other diseases tied to the overactivity of antibodies. Published in the journal, ...
The findings are published in the journal Aging Cell. Professor of Health Sciences Newman Sze and his international team have identified a specific antibody ... fibrosis is one of many diseases ...
IgGenix, Inc., a clinical-stage biotechnology company pioneering innovative treatments for immune-mediated diseases, today ...
Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果